A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.

BACKGROUND The independent contributions of subfractions of high-density lipoprotein (HDL) cholesterol (HDL2 and HDL3) and apolipoproteins in predicting the risk of myocardial infarction are unclear. Prospective data are sparse, but HDL2 is widely believed to be a more important predictor than HDL3. METHODS Blood samples were collected at base line from 14,916 men (ages, 40 to 84 years) who were participants in the Physicians' Health Study. After five years of follow-up, plasma samples from 246 men with new myocardial infarction (case subjects) were analyzed together with specimens from 246 men matched to them for age and smoking status who had not had a myocardial infarction. RESULTS The levels of total cholesterol and apolipoprotein B-100 were significantly associated with an increased risk of myocardial infarction (data on levels of low-density lipoprotein cholesterol were unavailable). Both HDL cholesterol and HDL2 levels were associated with a substantially decreased risk of myocardial infarction, but the HDL3 level was the strongest predictor; the relative risk was 0.3 (95 percent confidence interval, 0.2 to 0.6) for those in the fifth of the group with the highest HDL3 levels, as compared with the fifth with the lowest levels. The benefit of a higher HDL cholesterol level was most pronounced among those with lower total cholesterol levels. Levels of apolipoprotein A-I and apolipoprotein A-II were also associated with decreased risk. However, the levels of HDL subfractions and apolipoproteins did not add significantly to the value of a multivariate model that included the ratio of total to HDL cholesterol in predicting myocardial infarction, whereas that ratio remained a significant independent predictor of risk. After adjustment for other risk factors, a change of one unit in the ratio of total to HDL cholesterol was associated with a 53 percent change in risk (95 percent confidence interval, 26 percent to 85 percent). CONCLUSIONS This study underscores the importance of HDL cholesterol in predicting the risk of myocardial infarction and demonstrates protective effects of both the HDL3 and HDL2 subfractions of HDL cholesterol. We found little or no predictive value for the levels of apolipoproteins A-I, A-II, and B or HDL subfractions after conventional risk factors and the ratio of total to HDL cholesterol were considered.

[1]  S. Satterfield,et al.  Biochemical markers of compliance in the Physicians' Health Study. , 1990, American Journal of Preventive Medicine.

[2]  T. Ohta,et al.  Ageand Sex‐related Differences in Lipoproteins Containing Apoprotein A‐I , 1989, Arteriosclerosis.

[3]  D. Gordon,et al.  High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. , 1989, Circulation.

[4]  E. Nikkilä,et al.  Serum lipoproteins in patients with myocardial infarction. , 1988, Atherosclerosis.

[5]  S. Johansson,et al.  Serum lipids and apolipoprotein levels in women with acute myocardial infarction. , 1988, Arteriosclerosis.

[6]  N. Miller.  Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. , 1987, American heart journal.

[7]  H. Kempen,et al.  Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function. , 1987, The Journal of laboratory and clinical medicine.

[8]  B. Grab,et al.  Apoprotein D in a healthy, male population and in male myocardial infarction patients and their male, first-degree relatives. , 1986, Atherosclerosis.

[9]  N. Al-Muhtaseb,et al.  Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction , 1986 .

[10]  L. Wallentin,et al.  HDL2 and HDL3 lipid levels in coronary artery disease. , 1986, Atherosclerosis.

[11]  E. Alanen,et al.  Levels of serum lipids, apolipoproteins A-I and B and pseudocholinesterase activity and their discriminative values in patients with coronary by-pass operation. , 1986, Atherosclerosis.

[12]  Y. Friedlander,et al.  Analysis of risk factors in 532 survivors of first myocardial infarction hospitalized in Jerusalem. , 1986, Atherosclerosis.

[13]  G. Fex,et al.  Low serum apolipoprotein A-I in acute myocardial infarction survivors with normal HDL cholesterol. , 1986, Atherosclerosis.

[14]  P. Bachorik,et al.  Precipitation methods for quantification of lipoproteins. , 1986, Methods in enzymology.

[15]  M. Laakso,et al.  Association of Low HDL and HDL2 Cholesterol with Coronary Heart Disease in Noninsulin‐Dependent Diabetics , 1985, Arteriosclerosis.

[16]  J. Salonen,et al.  Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease. , 1985, The American journal of cardiology.

[17]  J. Larosa,et al.  Lipoprotein and apolipoprotein levels in angiographically defined coronary atherosclerosis. , 1985, The American journal of cardiology.

[18]  P. Nestel,et al.  Lipoprotein predictors of the severity of coronary artery disease in men and women. , 1985, Circulation.

[19]  W. Willett,et al.  The 2 × 2 factorial design: Its application to a randomized trial of aspirin and U.S. physicians , 1985 .

[20]  G. Kostner,et al.  Total plasma apo E and high density lipoprotein apo E in survivors of myocardial infarction. , 1984, Atherosclerosis.

[21]  K. Hiwada,et al.  Serum apolipoprotein A-I, A-II and B levels and their discriminative values in relatives of patients with coronary artery disease. , 1984, Atherosclerosis.

[22]  S. Kelsey,et al.  The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study. , 1984, Circulation.

[23]  A. Noma,et al.  Plasma lipids and apolipoproteins as discriminators for presence and severity of angiographically defined coronary artery disease. , 1983, Atherosclerosis.

[24]  A. Zinsmeister,et al.  Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease. , 1983, The New England journal of medicine.

[25]  Norman E. Breslow,et al.  Maximum Likelihood Fitting of General Risk Models to Stratified Data , 1983 .

[26]  G. Miller,et al.  Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. , 1982, Journal of lipid research.

[27]  W. Markiewicz,et al.  High-density Lipoprotein Subfractions in Normolipidemic Patients with Coronary Atherosclerosis , 1982, Circulation.

[28]  D. Ballantyne,et al.  High density and low density lipoprotein subfractions in survivors of myocardial infarction and in control subjects. , 1982, Metabolism: clinical and experimental.

[29]  J. Deslypere,et al.  Discriminative value of lipids and apoproteins in coronary heart disease. , 1982, Atherosclerosis.

[30]  J. Fruchart,et al.  Lipoproteins, apolipoproteins and coronary artery disease assessed by coronary arteriography , 1982 .

[31]  L Wilhelmsen,et al.  Multivariate Analyses of Serum Apolipoproteins and Risk Factors in Relation to Acute Myocardial Infarction , 1981, Arteriosclerosis.

[32]  B. Lewis,et al.  Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. , 1981, British medical journal.

[33]  C. Wilhelmsson,et al.  Serum apolipoprotein levels in relation to acute myocardial infarction and its risk factors--determination of apolipoprotein D. , 1980, Atherosclerosis.

[34]  G. Cazzolato,et al.  Relationship between apolipoproteins and chemical components of lipoproteins in survivors of myocardial infarction. , 1980, Atherosclerosis.

[35]  W. Riesen,et al.  Apoproteins and lipids as discriminators of severity of coronary heart disease. , 1980, Atherosclerosis.

[36]  C. Wilhelmsson,et al.  Serum apolipoprotein levels in relation to acute myocardial infarction and its risk factors. Apolipoprotein A-I levels in male survivors of myocardial infarction. , 1980, Atherosclerosis.

[37]  G. Assmann,et al.  Lipoprotein and apoprotein values in coronary angiography patients. , 1980, Artery.

[38]  G. Cazzolato,et al.  ARE APOLIPOPROTEINS BETTER DISCRIMINATORS THAN LIPIDS FOR ATHEROSCLEROSIS? , 1979, The Lancet.

[39]  J. Medalie,et al.  High density lipoprotein cholesterol and incidence of coronary heart disease--the Israeli Ischemic Heart Disease Study. , 1979, American journal of epidemiology.

[40]  I. Holme,et al.  High density lipoprotein cholesterol and myocardial infarction or sudden coronary death: a prospective case-control study in middle-aged men of the Oslo study. , 1979, Artery.

[41]  D. Thelle,et al.  The Tromsø Heart Study: Serum apolipoprotein Al concentration in relation to future coronary heart disease , 1978, European journal of clinical investigation.

[42]  W. Hazzard,et al.  High-density lipoproteins in myocardial infarction survivors. , 1978, Metabolism: clinical and experimental.

[43]  D. Thelle,et al.  THE TROMSØHEART-STUDY HIGH-DENSITY LIPOPROTEIN AND CORONARY HEART-DISEASE: A PROSPECTIVE CASE-CONTROL STUDY , 1977, The Lancet.

[44]  A. Børresen,et al.  SERUM-H.D.L.IN ATHEROSCLEROTIC HEART-DISEASE , 1976, The Lancet.

[45]  P. Wahl,et al.  Quantitation of apolipoprotein A-I of human plasma high density lipoprotein. , 1976, Metabolism: clinical and experimental.

[46]  A. Børresen,et al.  SERUM-HIGH-DENSITY-LIPOPROTEIN AND ATHEROSCLEROTIC HEART-DISEASE , 1976, The Lancet.

[47]  W Young,et al.  Ischemic Heart Disease, Atherosclerosis, and Longevity , 1966, Circulation.